According to current research, there is almost no correlation between TMB and PD-L1 expression in many cancers and their subtypes, including NSCLC, CRC, melanoma, and pancreatic cancer, which indicates that the TMB can serve as an independent prognostic marker (19, 20). The gene discussed is CD274; the disease is colorectal carcinoma.